The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Langer Dennis since year 2005.
The trader's CIK number is 1274225.
At the time of this reporting, Langer Dennis is the Director of Dicerna Pharmaceuticals Inc .
(stock ticker symbol DRNA).
See this page for all insider trading activities at Dicerna Pharmaceuticals Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-01-26 | DRNA | Dicerna Pharmaceuticals Inc | Option Ex | 360 | 3.42 | 1,231 |
| 2016-11-16 | DRNA | Dicerna Pharmaceuticals Inc | Sale | 23,766 | 3.52 | 83,656 |
| 2016-02-03 | DRNA | Dicerna Pharmaceuticals Inc | Option Ex | 34,722 | 3.42 | 118,749 |
| 2012-11-29 | MYGN | Myriad Genetics Inc | Option Ex | 25,000 | 13.53 | 338,250 |
| 2012-11-30 | MYGN | Myriad Genetics Inc | Option Ex | 45,000 | 19.06 | 857,700 |
| 2012-11-29 | MYGN | Myriad Genetics Inc | Sale | 25,000 | 29.82 | 745,500 |
| 2012-11-30 | MYGN | Myriad Genetics Inc | Sale | 45,000 | 29.91 | 1,345,725 |
| 2009-02-05 | MYGN | Myriad Genetics Inc | Option Ex | 15,000 | 25.73 | 386,025 |
| 2009-02-05 | MYGN | Myriad Genetics Inc | Sale | 15,000 | 82.72 | 1,240,725 |
| 2008-09-04 | MYGN | Myriad Genetics Inc | Option Ex | 5,720 | 21.49 | 122,922 |
| 2008-09-05 | MYGN | Myriad Genetics Inc | Option Ex | 4,280 | 21.49 | 91,977 |
| 2008-09-04 | MYGN | Myriad Genetics Inc | Sale | 5,720 | 65.73 | 375,969 |
| 2008-09-05 | MYGN | Myriad Genetics Inc | Sale | 4,280 | 63.50 | 271,780 |
| 2007-12-19 | MYGN | Myriad Genetics Inc | Option Ex | 10,000 | 17.23 | 172,300 |
| 2007-12-20 | MYGN | Myriad Genetics Inc | Option Ex | 20,000 | 19.09 | 381,740 |
| 2007-12-19 | MYGN | Myriad Genetics Inc | Sale | 10,000 | 47.52 | 475,150 |
| 2007-12-20 | MYGN | Myriad Genetics Inc | Sale | 20,000 | 47.62 | 952,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Langer Dennis (Director of Dicerna Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.